The therapeutic applications of 1,2,4-triazoles motivated us to synthesize some new derivatives. Two series of
Introduction
Triazole is an aromatic heterocyclic class of compounds containing two carbon atoms and three nitrogen atoms. There are two types of triazoles on the basis of arrangements of nitrogen atoms in five-member heterocyclic rings, 1,2,3-triazole and 1,2,4-triazole. Triazoles are well known for their biological activities and are excessively used as building blocks for the synthesis of a variety of organic compounds.
1 Triazoles are reported as good ligands for chelating polymers that are used for the removal of heavy metals from waste water. 2 Triazoles are well-known pharmacological agents 3 due to a range of bioactivities including anticancer, 4 antimicrobial, 11 Mammalian α -glucosidase anchored in the mucosal brush border of the small intestine catalyzes the end-step digestion of starch and sucrose, which are abundant carbohydrates in the human diet. 12 α -Glucosidase inhibitors delay the breakdown of carbohydrate in the small intestine and diminish the postprandial blood glucose excursion in diabetic subjects. 13 Thus, these have a lowering effect on postprandial blood glucose and insulin levels. Commercially available α -glucosidase inhibitors such as acarbose, miglitol, and voglibose are widely used to treat patients with type II diabetes.
3−5,8−10,14
Some series of sulfonamides were previously synthesized by our group and found to possess inhibition potential against the α -glucosidase enzyme. 15−17 These compounds previously synthesized by our group and a literature review 3−5,8−10 of triazoles prompted us to synthesize some series of compounds bearing these active functionalities. In search of new biologically potent molecules with the least toxicity, two new series of S -substituted derivatives of 5-{ 1-[(4-chlorophenyl)sulfonyl]-3-piperidinyl}-4-phenyl-4H -1,2,4-triazol-3-thiol were synthesized. A variety of functional moieties have been grouped together as a single unit to enhance their pharmaceutical potential. All the derivatives were screened for α -glucosidase inhibition and hemolytic activity. Most of the derivatives revealed moderate to good α -glucosidase inhibition potential. The most potent molecules might be further processed for the control of type II diabetes.
Result and discussion
The synthetic route for the title compounds (8a-8j, 12a-12i) is described in the Scheme. The structures of all synthesized derivatives were elucidated by spectroscopic data analysis. The screening against the α -glucosidase enzyme revealed most of the synthesized compounds as good inhibiting agents that might be used for the treatment of type II diabetes. Two compounds, 8a and 8j, were found inactive. The results for α -glucosidase enzyme inhibition and hemolytic activity are given in Table 1 . The molecular docking interactions are listed in Table 2 .
Chemistry
Ethyl 1-[(4-chlorophenyl)sulfonyl] piperidine-3-carboxylate (3) was synthesized from ethyl nipecotate (2) and 4-chlorophenylsulfonyl chloride (1) and then refluxed with hydrated hydrazine in methanol. The resultant hydrazide was refluxed with phenyl isothiocyanate and subsequently the product obtained was cyclized on reflux in the presence of 10% NaOH to get compound 6. A series of N -aralkyl/aryl-2-bromoacetamides (11a-11i)
was prepared from N -aralkyl/aryl amines (10a-10i). Target compounds (8a-8j, 12a-12i) were synthesized by gearing up compound 6 with a series of alkyl halides (7a-7j) and a series of N -aralkyl/aryl-2-bromoacetamides (11a-11i).
The molecular formulae of the synthesized compounds were established through their EIMS spectral data and the integration curves of protons in their 1 H NMR spectra. In the IR spectra, the C = N and C - 12i, sometimes the moiety formed by the fragmentation of aralkyl/aryl amine appeared as a base peak. EIMS spectra confirmed the M + peaks for all derivatives. On the basis of all these spectroscopic data, the structures of all synthesized derivatives were corroborated.
Hemolytic activity
All derivatives (8a-8j, 12a-12i) were screened for hemolytic activity. The % lysis values are described in Table   1 for each derivative. Phosphate-buffered saline (PBS) was used as a negative control while Triton X-100 was the positive control. Compounds 8b, 8j, 12d, and 12f were reported to possess the highest % lysis at 11.6, 11.5, 12.4, and 12, respectively. The lowest % lysis was recorded for compound 8h as 5.5, probably because of the S -substituted straight-chain heptyl group exhibiting an electron-donating effect. Compounds 12h and 12i also exhibited low % lysis potential at 6 and 6.3, respectively, probably due to the ethoxy-substituted phenyl ring, which exhibited an electron-donating effect. The low % lysis of the derivatives rendered them the least cytotoxic.
α -Glucosidase inhibition and molecular docking
All derivatives 8a-8j and 12a-12i were screened for α -glucosidase inhibitory potential and found to exhibit excellent to moderate inhibitory action. Acarbose was used as a positive control. The % inhibition and IC 50 values are presented in Table 1 . To study the interactions responsible for the α -glucosidase inhibitory potential of the target compounds, molecular docking studies were carried out. The different molecular interactions of the most active compounds are listed in Table 2 . Some of the derivatives revealed excellent IC 50 values, even better than those of the positive control, acarbose. Compounds 8c, 8g, 12d, 12f, 12g, and 12i revealed excellent IC 50 (µ M) values of 21.23 ± 0.05, 35.28 ± 0.02, 34.27 ± 0.11, 31.23 ± 0.08, 35.24 ± 0.12, and 31.24 ± 0.13, respectively, as compared to that of acarbose, 37.38 ± 0.12. These six compounds exhibited better inhibition potential than that of acarbose. The excellent inhibitory potential of 8c and 8g may be credited to the presence of isopropyl and 2-pentyl groups attached to the triazole ring through sulfur, respectively. Among all the aliphatic groups, the branched ones remained more efficient and those are also propyl and pentyl groups. Among the remaining compounds, 8f bearing a 1-pentyl group showed moderate activity, having an IC 50 value of 53.42 ± 0.03 µ M. Compounds 8a and 8j, bearing ethyl and allyl groups, respectively, were found to be inactive. Molecular docking studies revealed that compound 8c exhibited acidic, arene-cation, and arene-arene interactions among Lys422, Arg404, and Trp271 of the α -glucosidase enzyme with bond lengths (Å) of 2.25, 3.44, and 3.78, respectively. A strong hydrogen bond interaction was observed with Lys422 of the glucosidase enzyme by the oxygen of the sulfonyl group. These strong interactions and the three-dimensional orientation of compound 8c might be responsible for its excellent α -glucosidase inhibitory potential ( Figure 1 ). Compound 8g exhibited one acidic and one arene-cation interaction with Lys422 and Arg404 of the glucosidase enzyme with bond lengths (Å) of 2.41 and 3.48, respectively. The acidic interaction was shown by the sulfonyl group with Lys422 and arene-cation interaction by the phenyl ring attached to the triazole moiety with Arg404 of the glucosidase enzyme. These strong interactions with short bond distances and 3D-orientation adopted by the sec-pentyl-substituted compound might be responsible for α -glucosidase inhibitory potential ( Figure   2 ). The excellent inhibitory potential of 12d, 12f, 12g, and 12i may be attributed to the presence of 3-methylphenyl, 2-ethylphenyl, 4-ethylphenyl, and 4-ethoxyphenyl groups, respectively, attached to the nitrogen of amide functionality. The ethyl substitution was rendered more potent at both the ortho and para positions of the phenyl ring, but the substitution of methyl and ethoxy groups remained effective only at the meta and para positions, respectively. Among the remaining compounds, 12c and 12h, bearing 2-methylphenyl and 2-ethoxyphenyl, respectively, showed moderate activity, having IC 50 values of 41.16 ± 0.12 and 45.28 ± 0.12 µ M. Molecular docking studies revealed that Lys422 of the α -glucosidase enzyme showed one acidic and two arene-cation interactions with the sulfonyl oxygen, 4-chloro phenyl ring, and phenyl ring attached to the triazole moiety of ligand 12d indicating bond lengths (Å) of 2.54, 3.06, and 3.31, respectively. These strong acidic and arene-cation interactions might be responsible for the better inhibitory potential of compound 12d than that of the reference, acarbose ( 
Conclusions
The synthesized compounds were structurally elucidated by spectroscopic analysis. The bioactivity results in Table 1 and Table 2 show that the series of synthesized compounds presented notable inhibitory action against the α -glucosidase enzyme. The subtle variation in structure has greatly affected the bioactivity results. The most active molecules might be considered for drug development programs to treat type II diabetes.
Experimental

General
The chemicals required to carry out the presented research project were from Merck and Sigma-Aldrich and purchased from local suppliers. A Gallenkamp digital melting point apparatus was used to record the melting points of all synthesized derivatives by open capillary tube and were uncorrected. Purity of all derivatives was confirmed by TLC using EtOAc and n -hexane as the mobile phase. A UV lamp operating at 254 nm was used to observe the developed TLC. A Jasco FTIR spectrometer was used to record IR spectra through the KBr pellet method.
1 H NMR and 13 C NMR were recorded on Bruker spectrometers operating at 500 and 600
MHz and at 125 and 150 MHz, respectively, using chloroform-d 1 as solvent and TMS as reference standard. A JMS-HX 110 spectrometer was used to record EIMS spectra.
Synthesis of ethyl 1-[(4-chlorophenyl)sulfonyl]piperidine-3-carboxylate (3)
Ethyl piperidine-3-carboxylate (2; 0.05 mol) was suspended in an aqueous medium under controlled pH of 10-11. pH was controlled by drops of aqueous 5% Na 2 CO 3 solution. 4-Chlorobenzenesulfonyl chloride (1; 0.05 mol) was added gradually and the mixture was stirred for 3-4 h. Reaction completion was confirmed by TLC.
To quench the precipitates, cold distilled water was added and precipitates were filtered, washed, and dried.
Synthesis of 1-[(4-chlorophenyl)sulfonyl]piperidine-3-carbohydrazide (4)
Compound 3 (0.04 mol) and hydrazine hydrate (0.04 mol) were allowed to reflux in methanol (40 mL) for 5-6 h. Reaction completion was confirmed by TLC. Excess methanol was distilled off and cold water was used to obtain the precipitates. The formed precipitates were filtered, washed, and dried.
Synthesis of 2-({ 1-[(4-chlorophenyl)sulfonyl]-3-piperidinyl} carbonyl)-N -phenyl-1-hydrazinecarbothioamide (5)
Compound 4 (0.03 mol) was refluxed with phenyl isothiocyanate (0.03 mol) in the presence of methanol (100 mL) in a 250-mL round bottom flask for 3-4 h. Reaction was monitored by TLC. On completion of the reaction, methanol was distilled off and distilled water was added to separate out the precipitates. The product was filtered, washed, and dried.
Synthesis of 5-{ 1-[(4-chlorophenyl)sulfonyl]-3-piperidinyl}-4-phenyl-4H -1,2,4-triazol-3-thiol (6)
Compound 5 (0.02 mol) was refluxed in a basic aqueous medium of 10% NaOH solution for 2-3 h. Upon reaction completion, confirmed by TLC, the reaction mixture was allowed to cool to room temperature. Reaction contents were acidified by dil. HCl up to pH 4-5. White precipitates were collected, washed, and dried.
Synthesis of N -aralkyl/aryl-2-bromoacetamides (11a-11i)
N -substituted aralkyl/aryl amines (10a-10i, 5 mmol) were suspended in 5% Na 2 CO 3 solution and distilled water (15 mL), and dynamic pH was controlled at about 9-10. 2-Bromoacetyl bromide (9, 5 mmol) was introduced to the reaction flask slowly with vigorous shaking and set to stir for 30 min. Reaction completion and product purity were confirmed by TLC. The precipitates of N -aralkyl/aryl-2-bromoacetamides (11a-11i) were filtered, washed, and dried for the final step of reaction.
Synthesis of S -substituted derivatives of 5-{1-[(4-chlorophenyl)sulfonyl]-3-piperidinyl} -4-phenyl-4H -1,2,4-triazol-3-thiol (8a-8j, 12a-12i)
Compound 6 (0.2 g, 0.46 mmol) was stirred with NaH for 30 min in DMF (15 mL). Equimolar alkyl halides (7a-7j, 0.46 mmol) and N -aralkyl/aryl-2-bromoacetamides (11a-11i, 0.46 mmol) were added and stirred for 2-3 h. To collect the precipitates, distilled water was added to reaction contents followed by filtration, washing, and drying. ′ compound (0.5 mM). The reaction contents were preincubated at 37
5-{ 1-[(4-Chlorophenyl
(C -5), 152.4 (C -3), 139.4 (C -1 ′′ ), 134.9 (C -4 ′′ ), 132.7 (C -1 ′′′ ), 130.5 (C -4 ′′′ ), 130.3 (C -2 ′′ & C -6 ′′ ), 129.5 (C -3 ′′ & C -5 ′′ ), 128.9 (C -3 ′′′ & C -5 ′′′ ), 127.1 (C -2 ′′′ & C -6 ′′′ ), 49.4 (C -2 ′ ), 46.0 (C -6 ′ ), 34.4 (C -3 ′ ), 32.9 (C -1 ′′′′ ), 29.1 (C -4 ′ ), 24.3 (C -5 ′ ), 22.7 (C -2 ′′′′ ),
5-{ 1-[(4-Chlorophenyl)sulfonyl]-3-piperidinyl} -4-phenyl-4H -1,2,4-triazol-3-yl butan-1-yl sulfide (8d)
5-{ 1-[(4-Chlorophenyl)sulfonyl]-3-piperidinyl} -4-phenyl-4H -1,2,4-triazol-3-yl 1-methylpropan-1-yl sulfide (8e)
(C -1 ′′ ), 134.8 (C -4 ′′ ), 133.8 (C -1 ′′′ ), 130.4 (C -4 ′′′ ), 130.2 (C -2 ′′ & C -6 ′′ ), 129.5 (C -3 ′′ & C -5 ′′ ), 128.8 (C -3 ′′′ & C -5 ′′′ ), 127.1 (C -2 ′′′ & C -6 ′′′ ), 49.4 (C -2 ′ ), 46.0 (C -6 ′ ), 32.9 (C -3 ′ ), 32.5 (C -2 ′′′′ ), 30.7 (C -3 ′′′′ ), 29.1 (C -4 ′ ), 29.0 (C -1 ′′′′ ), 24.3 (C -5 ′ ), 22.1 (C -4 ′′′′ ),
5-{ 1-[(4-
Chlorophenyl132.9 (C -1 ′′′ ), 130.3 (C -2 ′′ & C -6 ′′ ), 130.1 (C -3 ′′ & C -5 ′′ ), 129.5 (C -3 ′′′ & C -5 ′′′ ), 128.9 (C -4 ′′′ ), 127.2 (C -2 ′′′ & C -6 ′′′ ), 49.4 (C -2 ′ ), 46.0 (C -6 ′ ), 43.3 (C -2 ′′′′ ), 38.8 (C -3 ′ ), 33.0 (C -1 ′′′′ ), 29.1 (C -4 ′ ), 24.3 (C -5 ′ ), 21.5 (C -5 ′′′′ ), 21.5 (C -3 ′′′′ ),3 (C -3), 139.4 (C -1 ′′ ), 134.7 (C -4 ′′ ), 132.8 (C -1 ′′′ ), 130.4 (C -2 ′′ & C -6 ′′ ), 130.2 (C -3 ′′ & C -5 ′′ ), 129.5 (C -3 ′′′ & C -5 ′′′ ), 128.9 (C - 2 ′′′ & C -6 ′′′ ), 127.1 (C -4 ′′′ ), 49.4 (C -2 ′ ), 46.0 (C -6 ′ ), 32.9 (C -3 ′ ), 32.5 (C -5 ′′′′ ), 31.6 (C -3 ′′′′ ), 29.3 (C -4 ′ ), 29.1 (C -4 ′′′′ ), 28.7 (C -2 ′′′′ ), 28.6 (C -1 ′′′′ ), 24.3 (C -5 ′ ), 22.5 (C -6 ′′′′ ), 14.0 (C -7 ′′′′ ); EIMS ( m/z): 535 [M + 2] + , 533 [M] + , 435 [C 19 H 18 ClN 4 O 2 S 2 ] •+ , 375 [C 18 H 18 ClN 3 O 2 S] •+ , 361 [C 18 H 18 ClN 2 O 2 S] + , 284 [C 12 H 13 ClN 2 O 2 S] •+ , 258 [C 11 H 13 ClNO 2 S] + , 175 [C 6 H 4 ClO 2 S] + , 99 [C 7 H 15 ] + , 111 [C 6 H 4 Cl] + , 43 [C 3 H 7 ] + .
5-{ 1-[(4-Chlorophenyl
3), 139.4 (C -1 ′′ ), 134.8 (C -4 ′′ ), 132.8 (C -1 ′′′ ), 130.4 (C -4 ′′′ ), 130.2 (C -2 ′′ & C -6 ′′ ), 129.4 (C -3 ′′ & C -5 ′′ ), 128.9 (C -3 ′′′ & C -5 ′′′ ), 127.1 (C -2 ′′′ & C -6 ′′′ ), 49.4 (C -2 ′ ), 46.0 (C -6 ′ ), 32.9 (C -3 ′ ), 32.5 (C -6 ′′′′ ), 31.7 (C -4 ′′′′ ), 29.3 (C -5 ′′′′ ), 29.1 (C -3 ′′′′ ), 29.1 (C -4 ′ ), 28.9 (C -2 ′′′′ ), 28.6 (C -1 ′′′′ ), 24.3 (C -5 ′ ),4 ′′ ), 134.8 (C -1 ′′′′′ ), 131.9 (C -1 ′′′ ), 131.0 (C -2 ′′ & C -6 ′′ ), 130.6 (C -3 ′′ & C -5 ′′ ), 129.5 (C -3 ′′′ & C - 5 ′′′ ), 128.9 (C -4 ′′′ , C -3 ′′′′′ & C -5 ′′′′′ ), 126.8 (C -2 ′′′ & C -6 ′′′ ), 124.2 (C -4 ′′′′′ ), 119.7 (C -2 ′′′′′ & C - 6 ′′′′′ ), 49.3 (C -2 ′ ), 46.0 (C -6 ′ ), 36.1 (C -3 ′ ), 32.9 (C -2 ′′′′ ), 29.1 (C -4 ′ ),
2-[(5-
• C for 10 min and preabsorbance was measured at 400 nm. p -Nitrophenyl glucopyranoside (substrate) (10 µ L, 0.5 mM) was added to initiate the reaction. Acarbose was used as a positive reference standard. The contents were incubated at 37
• C for 30 min and, using a Synergy HT microplate reader, absorbance was noted at 400 nm. Triplicate readings were taken. The percent inhibition was calculated by the following equation:
Here, Control is absorbance in control and Test is absorbance in test sample. IC 50 values of compounds were calculated using EZ-Fit Enzyme Kinetics Software (Perrella Scientific Inc., Amherst, NH, USA).
Statistical analysis
All measurements were done in triplicate and statistical analysis was performed with Microsoft Excel 2010.
Results are presented as mean ± SEM.
Molecular docking
In an attempt to learn about the inhibitory interactions bioinformatically, nineteen different synthesized compounds were docked in the active pocket of α -glucosidase by using the default parameters of the MOE-Dock program. Chemical structures of these nineteen ligands were drawn with ChemDraw Ultra 12.0 software and then opened in MOE software (2009) (2010) . Energy minimization was preceded up to 0.05 gradients by using the MMFF94X force field through the default parameter of the MOE energy minimization algorithm. All these compounds were saved in a separate database in the mdb file format. The protein molecule of α -glucosidase (PDB Code; 3NO4) was downloaded from the Protein Data Bank. All the water molecules were removed from the receptor protein and 3D protonation was carried out using the Protonate 3D option. In the same way, the energy of the protein molecule was also minimized by the default parameters of MOE 2009-2010 energy minimization algorithms (gradient: 0.05, force field: MMFF94X). Finally, all these compounds were docked into the binding pocket of the enzyme. For validity confirmation, a redocking procedure was applied. After docking analysis of each compound with 30 conformations, the best 2D images were saved for their specific types of interactions and their 3D images were drawn along with their bond lengths.
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